Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study

PURPOSE: To evaluate the effect of immunotherapy on response, survival, and certain immune markers in patients with small cell lung cancer (SCLC) who are receiving chemotherapy. PATIENTS AND METHODS: Patients with SCLC (n = 164) were assigned to receive either chemotherapy alone (group A) or a combi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Zarogoulidis, Konstantinos, Ziogas, Eftimios, Boutsikou, Efimia, Zarogoulidis, Paul, Darwiche, Kaid, Kontakiotis, Theodoros, Tsakiridis, Kosmas, Porpodis, Konstantinos, Latsios, Dimitrios, Chatzizisi, Olga, Karapantzos, Ilias, Li, Qiang, Kyriazis, Georgios
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2013
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3726438/
https://ncbi.nlm.nih.gov/pubmed/23901264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S43184
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg